[HTML][HTML] Strategies to inhibit Myc and their clinical applicability

JR Whitfield, ME Beaulieu, L Soucek - Frontiers in cell and …, 2017 - frontiersin.org
Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family
member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance …

Mitochondrial function—gatekeeper of intestinal epithelial cell homeostasis

E Rath, A Moschetta, D Haller - Nature reviews Gastroenterology & …, 2018 - nature.com
The intestinal epithelium is a multicellular interface in close proximity to a dense microbial
milieu that is completely renewed every 3–5 days. Pluripotent stem cells reside at the crypt …

[HTML][HTML] MYC-driven pathways in breast cancer subtypes

Y Fallah, J Brundage, P Allegakoen, AN Shajahan-Haq - Biomolecules, 2017 - mdpi.com
The transcription factor MYC (MYC proto-oncogene, bHLH transcription factor) is an
essential signaling hub in multiple cellular processes that sustain growth of many types of …

A comprehensive review on the applications of nano-biosensor-based approaches for non-communicable and communicable disease detection

RG Kerry, KE Ukhurebor, S Kumari, GK Maurya… - Biomaterials …, 2021 - pubs.rsc.org
The outstretched applications of biosensors in diverse domains has become the reason for
their attraction for scientific communities. Because they are analytical devices, they can …

Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target

OA Sukocheva, H Furuya, ML Ng, M Friedemann… - Pharmacology & …, 2020 - Elsevier
Inflammatory gastrointestinal (GI) diseases and malignancies are associated with growing
morbidity and cancer-related mortality worldwide. GI tumor and inflammatory cells contain …

[HTML][HTML] Allostery, and how to define and measure signal transduction

R Nussinov, CJ Tsai, H Jang - Biophysical chemistry, 2022 - Elsevier
Here we ask: What is productive signaling? How to define it, how to measure it, and most of
all, what are the parameters that determine it? Further, what determines the strength of …

[HTML][HTML] Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers

W Song, Y Hwang, VM Youngblood, RS Cook… - Oncogene, 2017 - nature.com
Basal-like/triple-negative breast cancers (TNBCs) are among the most aggressive forms of
breast cancer, and disproportionally affects young premenopausal women and women of …

Burkitt lymphoma in adolescents and young adults: management challenges

M Dozzo, F Carobolante, PM Donisi… - … health, medicine and …, 2016 - Taylor & Francis
About one-half of all Burkitt lymphoma (BL) patients are younger than 40 years, and one-
third belong to the adolescent and young adult (AYA) subset, defined by an age between 15 …

[HTML][HTML] MYC—an emerging player in mitochondrial diseases

J Purhonen, J Klefström, J Kallijärvi - Frontiers in Cell and …, 2023 - frontiersin.org
The mitochondrion is a major hub of cellular metabolism and involved directly or indirectly in
almost all biological processes of the cell. In mitochondrial diseases, compromised …

[HTML][HTML] Strategies to target the cancer driver MYC in tumor cells

LI Weber, M Hartl - Frontiers in Oncology, 2023 - frontiersin.org
The MYC oncoprotein functions as a master regulator of cellular transcription and executes
non-transcriptional tasks relevant to DNA replication and cell cycle regulation, thereby …